Conclusions
Le traitement des hémorragies actives repose sur les drogues vasoactives (somatostatine, octréotide, amines vasoactives associées le plus souvent à un traitement endoscopique en urgence différée. Les bétabloquants sont efficaces dans la prévention primaire et secondaire. En cas d’échec ou de mauvaise adhésion au traitement, les techniques endoscopiques sont efficaces, mais au prix de multiples séances et de contrôles réguliers. L’anastomose porto-cave et en particulier les PIPS sont efficaces, mais entrînent un assez grand nombre d’encéphalopathies porto-caves. La transplantation hépatique est le traitement idéal, puisqui’il traite à la fois l’hypertension portale et l’insuffisance hépato-cellulaire, mais il nepeut être réalisé que chez desmalades très sélectionnées.
Conclusion
The treatment of acute bleeding relies upon vasoactive drugs (somatostatin, octreotide, vasoactive amines), most of the time combined with an endoscopic treatment delayed after the emergency. Beta-adrenergic antagonists are efficient for primary and secondary prevention. In case of failure or poor compliance to the treatment, endoscopic techniques are efficient, but at the cost of multiple sessions and regular checkups. Porto-caval anastomoses, and in particular TIPS, are efficient but lead to a rather large number of hepatic encephalopathies. Liver transplanttaion is the ideal treatment, since it corrects at the same time portal hypertension and hepatocellular deficiency, but it can only be performed in highly selected patients.
Références
AL TRAIF I., SBEIH F., ABDULRAHMAN F.et al. — Randomized trial of ligationversus combined ligation and sclerotherapy for bleeding esophageal varices.Gastrointest. Endosc., 1999,50, 1–6.
BESSON I., INGRAND P., PERSON B.et al. — Sclerotherapy with pr without octreotide for acute variceal bleeding.N. Engl. J. Med., 1995,333, 555–560.
BARTON R.E., RÖSCH J., SAXON R.R., LAKIN P.C., PETERSEN B.D., KELLERS F.S. — TIPS: short and long-term results — a survey of 1750 patients.Semin. Intervent. Radiol., 1995,12, 364–367.
CABRERA J., MAYNAR M., GRANADOS R.et al. — Transjugular intrahepatic portosystemic shuntversus sclerotherapy in the elective treatment of variceal hemorrhage.Gastroenterology, 1996,110, 832–839.
CELLO J.P., RING E.J., OLCOTTT E.W.et al. — Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized, controlled trial.Ann. Int. Med., 1997,126, 858–865.
D’AMICO G., PAGLIARO L., BOSCH J. — The treatment of portal hypertension: a meta-analytic review.Hepatology, 1995,22, 332–354.
DE LA PENA J., RIVERO M., SANCHEZ E., FABREGA E., CRESPO J., PONS-ROMERO F. — Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: a prospective trial.Gastrointest. Endosc., 1999,49, 417–423.
DJURDJEVIC D., JANOSEVIC S., DAPCEVICet al. — Combined ligation and sclerotherapyversus ligation alone for eradication of bleeding esophageal varices: a randomized and prospective trial.Endoscopy, 1999,31, 286–290.
ELSAYED S.S., SHIHA G., HAMID M., FARAG F.M., AZZAM F., AWAD M. — Sclerotherapyversus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.Gut, 1996,38, 770–774.
GARCIA-VILLAREAL L., MARTINEZ-LAGARES F., SIERRA A.et al. — TIPSversus sclerotherapy for the prevention of variceal rebleeding: preliminary results of a randomized study.Hepatology, 1996,24, 208A.
GARG P., JOSHI Y.K., TANDON R.K. — Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: a prospective randomized study.Gastrointest. Endosc. 1999,50, 369–373.
GIMSON A.E.S., RAMAGE J.K., PANOS M.Z.et al. — Randomised trial of variceal banding ligationversus injection sclerotherapy for bleeding oesophageal varices.Lancet, 1993,342, 391–394.
GRACE N.D. — Diagnostic and treatment of gastrointestinal bleeding secondary to portal hypertension (Practice guidelines).Am. J. Gastroenterol., 1997,92, 1081–1091.
Groupe d’Etude des Anastomoses Intrahépatiques — TIPSvs sclerotherapy plus propranolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomized trial.Hepatology, 1995,22, A297.
HOU M.C., LIN H.C., KUO L.T., LEE F.Y., CHANG F.Y., LEE S.D. — The rebleeding course and long-term outcome of esophageal variceal hemorrhage after ligation: comparison with sclerotherapy.Scand. J. Gastroenterol., 1999,34, 1071–1076.
JALAN R., FORREST E.H., STANLEY A.J.et al. — A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices.Hepatology, 1997,26, 1115–1122.
LAINE N., EL-NEWIHI H.M., MIGIKOVSKY B., SLOANE R., GARCIA F. — Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices.Ann. Intern. Med., 1993,119, 1–7.
LEVACHER S., LETOURNELIN P., PATERON D.,et al. — Early administration of terlipressin plus glycerol trinitrate to control active eso-gastric bleeding in cirrhotic patients.Lancet, 1995,346, 865–868.
LO G.H., LAI K.H., CHENG J.S.et al. — A prospective randomized trial of sclerotherapyversus ligation in the management of bleeding esophageal varices.Hepatology, 1995,22, 466–471.
LO G.H., LAI K.H., CHENG J.S., HUANG R.L., WANG S.J., CHIANG H.T. — Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy.Gastrointest. Endosc., 1999,49, 428–436.
LO G.H., LAI K.H., CHENG J.S., LIN C.K., HSU P.I., CHIANG H.T. — Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial.J. Hepatol. 1999,31, 451–456.
LOPES G.M., GRACE N.D. — Gastroesophageal varices: prevention of bleeding and rebleeding.Gastroenterology clinics of north America, 1993,22, 801–820.
LUCAS A., D’AMICO G., LA GALLA R., MIDIRI M., MORABITO A., PAGLIARO L. — TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials.Radiology, 1999,212, 411–421.
McCORMACK G., AIDEN McCORMICK P. — Practical guide to the management of oesophageal varices.Drugs, 1999,57, 327–335.
MERLI M., SALERNO F., RIGGIO O.et al. — Transjugular intrahepatic portosystemic shuntversus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial.Hepatology, 1998,27, 40–45.
PAGLIARO L., D’AMICO G., SÖRENSEN T.I.A.et al. — Prevention of first bleeding in cirrhosis: a meta-analysis of randomized non surgical treatment.Ann. Intern. Med., 1992,117, 59–70.
PAGLIARO L., D’AMICO G., SÖRENSEN T.I.A.et al. — Portal hypertension in cirrhosis: natural history.In Portal hypertension, pathophysiology and treatment. J. Bosch et R. Groszmann éditeurs. Blackwell Scientific Publications, 1994, 72–92.
PAPATHEODORIDIS G.V., GOULIS J., LEANDRO G., PATCH D., BURROUGHS A.K. — Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis.Hepatology, 1999,30, 612–622.
PATCH D., ARMONIS A., SABIN C.et al. — Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding.Gut, 1999,44, 264–269.
PLANAS R., QUER J.C., BOIX J.et al. — A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding.Hepatology, 1994,20, 370–375.
POMIER-LAYRARGUES G., DUFRESNE M.P., BUI B.et al. — TIPSversus endoscopic variceal ligation in the prevention of variceal rebleeding in cirrhotic patients: a comparative randomized clinical trial (interim analysis).Hepatology, 1997,26, A137.
POYNARD T., CALES P., PASTA L.et al. — Béta-adrenergic-antagonists in the prevention of first gastrointestinal bleeding and oesophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials.N. Engl. J. Med., 1991,324, 1532–1538.
PRZEMIOSLO R.T., McNAIR A., WILLIAMS R. — Thrombin is effective in arresting bleeding from gastric variceal hemorrhage.Dig. Dis. Sci., 1999,44, 778–781.
RIGGIO O., MERLI M., PEDRETTI G.,et al. — Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors.Dig. Dis. Sci., 1996,41, 578–584.
RÖSSLE M., DEIBERT P., HAAG K.et al. — Randomised trial of transjugular-intrahepatic-portosystemic shuntversus endoscopy plus propranolol for prevention of variceal rebleeding.Lancet, 1997,249, 1043–1049.17
SANYAL AJ., FREEDMAN A.M., SHIFFMAN M.L., PURDUM P.P., LUKETIC V.A., CHEATHAM A.K. — Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.Hepatology, 1994,20, 46–55.
SANYAL A.J., FREEDMAN A.M., VELIMIR A.et al. — Transjugular intrahepatic portosystemic shunt compared with endoscopic sclerotherapy for the prevention of reccurent variceal hemorrhage: a randomized controlled trial.Ann. Int. Med., 1997,126, 849–857.
SANYAL A.J., FREEDMAN A.M., LUKETIC V.A.et al. — The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts.Gastroenterology, 1997,112, 889–898.
SARIN S., GUPTA R. — Endoscopic ligation plus sclerotherapy: two plus two make only three!.Gastrointest. endosc., 1999,50, 129–133.
SAUER P., THEILMANN L., STREMMEL W., BENZ C., RICHTER G.M., STIEHL A. — Transjugular intrahepatic portosystemic shuntversus sclerotherapy plus propranolol for rebleeding.Gastroenterology, 1997,113, 1623–1631.
SAUER P., THEILMANN L., BENZ C., RICHTER G., STREMMEL W., STIEHL A. — Transjugular intrahepatic portosystemic stent shuntversus endoscopic banding in the prevention of variceal rebleeding: interim analysis of a randomized study.Gastroenterology, 1997,111, A1374.
SHIELDS R., JENKINS S.A., BAXTER J.N. — A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices.J. Hepatol. 1992,16, 128–137.
SHIHA G., EL-SAYED S.S. — Gastric variceal ligation: a new technique.Gastrointest. Endosc., 1999,49, 437–441.
SHIM C.S., CHO J.Y., PARK Y.J.et al. — Mini-detachable snare ligation for the treatment of esophageal varices.Gastrointest. Endosc., 1990,50, 673–676.
SILVAIN C., CARPENTIER S., SAUTEREAU D. — Terlipressin plus transdermal nitroglycerin Vs. Octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial.Hepatology, 1993,18, 61–65.
STIEGMANN G.V., GOFF J.S., MICHALETZ-ONODY P.A.et al. — Endoscopic sclerotherapy as compared with endocopic ligation for bleeding esophageal varices.N. Engl. J. Med., 1992,326, 1527–1532.
SUNG J.J.Y., CGUNG C.W.L., LEUNG J.W.C., YUNG M.Y., KASSIANIDES C., LI A.K.C. — Octreotide infusion or emergency sclerotherapy for variceal haemorrhage.Lancet, 1993,342, 637–641.
TANOUE K., HASHIZUME M., WADA, H., OHTA M., KITANO S., SUGIMACHI K. — Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study.Gastrointestinal Endoscopy 1992,38, 582–585.
UMEHARA M., ONDA M., TAJIRI T., TOBA M., YOSHIDA H., YAMASHITA K. — Sclerotherapy plus ligationversus ligation for the treatment of esophageal varices: a prospective randomized study.Gastrointest. Endosc., 1999,50, 7–12.
VILLANUEVA C., ORTIZ J., SABAT M.et al. — Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial.Hepatology, 1999,30, 384–389.
Author information
Authors and Affiliations
About this article
Cite this article
Florent, C., Salah, O.I. Résultats des études contrôlées dans le traitement des hémorragies digestives liées à l’hypertension portale. Acta Endosc 30, 519–530 (2000). https://doi.org/10.1007/BF03026169
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03026169